Skip to content
10-K

Annual Report

VYCOR MEDICAL, INC. VYCO

0001493152-24-014837

← back to feed
Filed
Apr 16, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Apr 16, 2024 32.63M sh
Shares Diluted FY 2023 · Dec 31, 2022 31.71M sh
Capex FY 2023 · Dec 31, 2022 $2.78K
Operating Cash Flow FY 2023 · Dec 31, 2022 −$217.02K
Cash And Equivalents FY 2023 · Dec 31, 2022 $37.04K
Current Liabilities FY 2023 · Dec 31, 2022 $3.65M
Total Liabilities FY 2023 · Dec 31, 2022 $3.8M
Current Assets FY 2023 · Dec 31, 2022 $517.76K
Total Assets FY 2023 · Dec 31, 2022 $860.18K
Eps Diluted FY 2023 · Dec 31, 2022 −$0.02
Eps Basic FY 2023 · Dec 31, 2022 −$0.02
Sga Expense FY 2023 · Dec 31, 2022 $1.33M
Net Income FY 2023 · Dec 31, 2022 −$404.92K
Operating Income FY 2023 · Dec 31, 2022 −$306.51K
Gross Profit FY 2023 · Dec 31, 2022 $1.08M
Cost Of Revenue FY 2023 · Dec 31, 2022 $140.64K
Revenue FY 2023 · Dec 31, 2022 $1.22M
Stockholders Equity restated FY 2023 · Dec 31, 2021 $2.4M